Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AT-101 in Recurrent Glioblastoma (Phase II, Single-Arm)
CTR20150540Phase 2Terminated
- Sponsor
- Ascentage Pharma
- Start
- Aug 2017
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of r-(-)-gossypol acetic acid in glioblastoma (GBM), sponsored by Ascentage Pharma. Started Aug 2017; status: terminated.
02
Drugs
r-(-)-gossypol acetic acid
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on CTR20150540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150540.